Publication search results

Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods

Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods Authors: Sheinson D, Meng Y and Elsea D Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR 2021. 17-20 May 2021. Citation: Sheinson D, Meng Y and Elsea D. Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods. Virtual ISPOR 2021. 17-20 May […]

Uncategorised

17th May 2021

Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study

Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study Authors: Gill L, Burrell S, Chamberlayne J, Lombardelli S, Mora J, Mason N, Schurer M, Merkel M, Meninger S and Ko JJ Publication type: Journal article Publication name: Orphanet Journal of Rare Diseases Citation: Gill L, Burrell S, Chamberlayne […]

Uncategorised

26th April 2021

How the latest NICE methods consultation could impact your evidence generation strategy

How the latest NICE methods consultation could impact your evidence generation strategy Authors: Lee D and Birnie R Publication type: White paper Citation: Lee D and Birnie R. How the latest NICE methods consultation could impact your evidence generation strategy. White Paper. 2020. Available at: https://www.bresmed.com/wp-11-20-how-the-latest-nice-methods-consultation-could-impact-your-evidence-generation-strategy/. Link to publication ⟶ ⟵ Back to Search Results

Uncategorised

27th November 2020

Did the NICE technical engagement process deliver more efficient decision making?

Did the NICE technical engagement process deliver more efficient decision making? Authors: Barnes A, Qu T, Kidd R, Taylor S, Lilley C and Lee D. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Barnes A, Qu T, Kidd R, Taylor S, Lilley C and Lee D. Did the NICE technical […]

Uncategorised

16th November 2020

Context matters – a taxonomy of real-world data and evidence to support HTA decision-making

Context matters – a taxonomy of real-world data and evidence to support HTA decision-making Authors: Murphy L, Mestre Ferrandiz J, Solà-Morales O, de Pouvourville G, Cunningham D, Corry S and Akehurst R. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Murphy L, Mestre Ferrandiz J, Solà-Morales O, de Pouvourville G, […]

Uncategorised

Matching-adjusted indirect treatment comparisons of the effect of lorlatinib versus chemotherapy on overall survival and progression-free survival for patients with second-line or later anaplastic lymphoma kinase-positive advanced non-small cell lung cancer

Matching-adjusted indirect treatment comparisons of the effect of lorlatinib versus chemotherapy on overall survival and progression-free survival for patients with second-line or later anaplastic lymphoma kinase-positive advanced non-small cell lung cancer Authors: Smith S, Albuquerque de Almeida F, Inês M, Iadeluca L and Cooper M. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR […]

Uncategorised

A review of consistencies in decision-making across NICE health technology assessments of immune heckpoint inhibitors

A review of consistencies in decision-making across NICE health technology assessments of immune heckpoint inhibitors Authors: Hale O, Casson J, Horscroft J, Sullivan W and Kiff C. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Hale O, Casson J, Horscroft J, Sullivan W and Kiff C. A review of consistencies […]

Uncategorised

Cost-effectiveness analysis of NOVEL therapies for HER2+ metastatic breast cancer- [FAM-] trastuzumab deruxtecan versus tucatinib trastuzumab and capecitabine

Cost-effectiveness analysis of NOVEL therapies for HER2+ metastatic breast cancer- [FAM-] trastuzumab deruxtecan versus tucatinib trastuzumab and capecitabine Authors: Vondeling G, Palaka E, Livings C, Naik J and Sullivan W Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Vondeling G, Palaka E, Livings C, Naik J and Sullivan W. Cost-effectiveness […]

Uncategorised

Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece

Cost-effectiveness analysis of lorlatinib in patients previously treated with anaplastic lymphoma kinase inhibitors for non-small cell lung cancer in Greece Authors: Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, Michailidi C, Lowry C, Tzanetakos C and Kourlaba G. Publication type: Conference Proceedings – Poster Publication Name: Virtual ISPOR Europe 2020 Citation: Gourzoulidis G, Zisimopoulou O, Boubouchairopoulou N, […]

Uncategorised

An incremental effectiveness analysis of lorlatinib for the treatment of ALK-positive advanced non-small cell lung cancer that has progressed after another ALK tyrosine kinase inhibitor in Portugal

An incremental effectiveness analysis of lorlatinib for the treatment of ALK-positive advanced non-small cell lung cancer that has progressed after another ALK tyrosine kinase inhibitor in Portugal Authors: Guerreiro R, Paquete A, Iadeluca L, Almond C, Albuquerque de Almeida F, Inês M, Costa J, Borges M and Silva Miguel L Publication type: Conference Proceedings – […]

Uncategorised